Randy W. Jackson - Concepedia

Author

Randy W. Jackson

VenatoRx Pharmaceuticals (United States)

Also Known As

R Jackson, R. W. JACKSON, R. W. Jackson, Randy Jackson, Randy W Jackson, Randy W. Jackson, Randy W. Jackson, Robert K. Jackson

Publications

896

Citations

H-Index

Concepts

All Affiliations

VenatoRx Pharmaceuticals (United States)University of California, Irvine Irvine University University of North Texas University of Siena

About

Randy W. Jackson is an author at VenatoRx Pharmaceuticals (United States) specializing in drug discovery, medicine, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	216
2	Biochemistry	6	6	169
3	Natural Sciences	4	4	106
4	Engineering	3	3	85
5	Biomolecular Engineering	3	3	85

Randy W. Jackson

Publications

827

Citations

H-Index

Page 1

	Year	Citations
Discovery of Taniborbactam (VNRX-5133): A Broad-Spectrum Serine- and Metallo-β-lactamase Inhibitor for Carbapenem-Resistant Bacterial Infections Bin Liu, Robert E. Lee Trout, Guo‐Hua Chu, Journal of Medicinal Chemistry	2019	281
VNRX-5133 (Taniborbactam), a Broad-Spectrum Inhibitor of Serine- and Metallo-β-Lactamases, Restores Activity of Cefepime in <i>Enterobacterales</i> and Pseudomonas aeruginosa Jodie C. Hamrick, Jean‐Denis Docquier, Tsuyoshi Uehara, Antimicrobial Agents and Chemotherapy	2019	204
Total Synthesis of the Antiparasitic Agent Avermectin B1a James D. White, Gary L. Bolton, Anura P. Dantanarayana, Journal of the American Chemical Society Donut IconMedicineAntiparasitic AgentAltmetric Attention ScoreTotal Synthesis	1995	90
A mild and selective method for the cleavage of tert-butyl esters Randy W. Jackson Tetrahedron Letters Tert-butyl EstersDerivative (Chemistry)EngineeringBiochemistryNatural Sciences	2001	43
Discovery of VNRX-7145 (VNRX-5236 Etzadroxil): An Orally Bioavailable β-Lactamase Inhibitor for Enterobacterales Expressing Ambler Class A, C, and D Enzymes Robert E. Lee Trout, Allison L. Zulli, Eugen F. Mesaros, Journal of Medicinal Chemistry	2021	41
Synthesis of a C-1 epi taxinine intermediate using the type 2 intramolecular Diels-Alder approach Randy W. Jackson, Kenneth J. Shea Tetrahedron Letters Intramolecular Diels-alder ApproachBiochemistryMedicineType 2Organic Chemistry	1994	40
The chemistry of C-aromatic taxane derivatives atropisomer control of reaction stereochemistry Randy W. Jackson, Richard G. Higby, Jeffrey W. Gilman, Tetrahedron C-aromatic Taxane DerivativesEngineeringOrganic ChemistryStereoselective SynthesisChemistry	1992	29
The Discovery of Pyrano[3,4‐<i>b</i>]indole‐Based Allosteric Inhibitors of HCV NS5B Polymerase with In Vivo Activity Matthew G. LaPorte, Randy W. Jackson, Tandy L. Draper, ChemMedChem ImmunologyAllosteric InhibitorsAntiviral DrugMedicinal ChemistryViral Hepatitis	2008	28
The discovery and structure–activity relationships of pyrano[3,4-b]indole-based inhibitors of hepatitis C virus NS5B polymerase Randy W. Jackson, Matthew G. LaPorte, Torsten Herbertz, Bioorganic & Medicinal Chemistry Letters Viral Polymerase StructureBiochemistryMedicineAntiviral Drug DevelopmentAntiviral Therapy	2011	23
Total synthesis of rutamycin B via Suzuki macrocyclization James D. White, Randy W. Jackson, Roger Hanselmann Chemical Communications Ring ClosureMedicinal ChemistryMacrolide Rutamycin BBiochemistryNatural Sciences	1998	21

Page 1